Gradipore director John Manusu, one of the founders of the Sydney company, has called for a general meeting on June 30 to remove the other four directors and elect two new ones. [ + ]

The report on the protection of human genetic information released yesterday by the Australian Law Reform Commission and the NHMRC's Australian Health Ethics Committee (AHEC) was the most comprehensive review on the laws covering genetic information and privacy in the world, according to Prof Don Chalmers, dean of law at the University of Tasmania. [ + ]

Leon Ivory, the founder of Perth-based VRI BioMedical, resigned last night, effectively bringing to a close two months of sometimes bitter feuding between the company's board and one of its largest shareholders. [ + ]

UNSW's molecular biology department has collaborated with the university's fine arts department to launch a unique online genome research laboratory, Visualising the Science of Genomics (VSG). [ + ]

University of Queensland and Institute for Molecular Biology researcher Prof David Craik has isolated a protein that could help stop the advance of the voracious Helicoverpa caterpillar through our agricultural backyard. [ + ]

Trading in shares of Sydney-based company Gradipore were halted this afternoon after one of the company's directors sought to call a shareholder meeting to remove four directors from the board and elect two new ones. [ + ]

Sydney-based clinical systems company Détente Systems has scored a major international coup, selling its gene database system to the prestigious Great Ormond Street Hospital (GOSH) in the UK. [ + ]

Sydney's Brain Resource Company, a compiler of global brain function databases, has benefited from a 13.5 per cent, $AUD2.5 million share buy from a mystery investor. [ + ]

With Cephalon and its takeover retiring behind the sidelines - officially, at least -- Sirtex is back to business, according to founder and CEO Bruce Gray. With a changed team if necessary. [ + ]

Melbourne company Genetic Technologies (GTG) has introduced a twist in its licensing strategy by offering companies the chance to be forgiven for past transgressions of GTG's non-coding DNA patents. [ + ]

EvoGenix has won $900,000 from the latest round of federal government R&D Start grant awards, adding a major boost to its R&D program over the next two years. [ + ]

Researchers at the University of Technology, Sydney have undertaken the first comprehensive and scientifically rigorous research into the effects of acupuncture on pain threshold, clarifying some of the basic assumptions about traditional Chinese acupuncture.

Sirtex shareholders watched their stocks slump today as potential takeover candidate Cephalon pulled out after acceptance had not reached the stated 90 per cent condition. [ + ]

Melbourne drug discovery company Cytopia has claimed its lead anti-cancer compounds were active in vitro against a common form of childhood cancer. [ + ]

Sydney biotech Peptech has reported "outstanding" results from a cut-down experimental antibody molecule as potential treatment for the crippling autoimmune disorder, rheumatoid arthritis. [ + ]